Scholarlink

Background <p>Amiodarone-induced thyrotoxicosis (AIT) is a serious complication of long-term amiodarone therapy. Its most severe manifestation is thyrotoxic crisis (TxC), a rare but life-threatening condition.</p> Aim <p>To analyze patients with AIT, identify demographic and clinical parameters, evaluate diagnostic and therapeutic approaches, and determine predictive risk factors for TxC.</p> Methods <p>A retrospective study of 55 consecutive patients with confirmed AIT followed between 2005 and 2024. Baseline characteristics, laboratory findings, thyroid ultrasound, clinical presentation, therapy and outcomes were analyzed. Patients were classified into AIT type 1, type 2, or mixed type. TxC was diagnosed using the Burch–Wartofsky scoring system.</p> Results <p>The cohort comprised 45 men (82%) and 10 women (18%) with a mean age of 62.3 ± 9.9&#xa0;years. Amiodarone was most commonly prescribed for atrial fibrillation (78%), and the mean duration of therapy before AIT onset was 988 ± 502&#xa0;days. Mean fT4 at diagnosis was 43.2 ± 18.3&#xa0;pmol/L and mean TSH 0.017 ± 0.052&#xa0;mIU/L. AIT type 1 was identified in 23%, type 2 in 44%, and mixed type in 33% of patients. TxC developed in 6 patients (11%). These patients were all men, had higher maximum fT4 levels (&gt; 74.5&#xa0;pmol/L) and larger thyroid volume (&gt; 19&#xa0;mL), and urgent thyroidectomy was required in 5 cases.</p> Conclusion <p>TxC occurred in 11% of patients with AIT and was associated with higher thyroid hormone levels and larger thyroid volume. Early recognition and interdisciplinary management are essential for improving outcomes.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Amiodarone-Induced Thyrotoxicosis and Clinical Risk Factors for Thyrotoxic Crisis

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月7日

查看全文
  • Marianna Bystrianska,
  • Adrian Bystriansky,
  • Iveta Wildova,
  • Zuzana Mesarosova,
  • Nadezda Petejova

摘要

Background

Amiodarone-induced thyrotoxicosis (AIT) is a serious complication of long-term amiodarone therapy. Its most severe manifestation is thyrotoxic crisis (TxC), a rare but life-threatening condition.

Aim

To analyze patients with AIT, identify demographic and clinical parameters, evaluate diagnostic and therapeutic approaches, and determine predictive risk factors for TxC.

Methods

A retrospective study of 55 consecutive patients with confirmed AIT followed between 2005 and 2024. Baseline characteristics, laboratory findings, thyroid ultrasound, clinical presentation, therapy and outcomes were analyzed. Patients were classified into AIT type 1, type 2, or mixed type. TxC was diagnosed using the Burch–Wartofsky scoring system.

Results

The cohort comprised 45 men (82%) and 10 women (18%) with a mean age of 62.3 ± 9.9 years. Amiodarone was most commonly prescribed for atrial fibrillation (78%), and the mean duration of therapy before AIT onset was 988 ± 502 days. Mean fT4 at diagnosis was 43.2 ± 18.3 pmol/L and mean TSH 0.017 ± 0.052 mIU/L. AIT type 1 was identified in 23%, type 2 in 44%, and mixed type in 33% of patients. TxC developed in 6 patients (11%). These patients were all men, had higher maximum fT4 levels (> 74.5 pmol/L) and larger thyroid volume (> 19 mL), and urgent thyroidectomy was required in 5 cases.

Conclusion

TxC occurred in 11% of patients with AIT and was associated with higher thyroid hormone levels and larger thyroid volume. Early recognition and interdisciplinary management are essential for improving outcomes.